儿童血液瘤学中的息护理需求:跨阶段的亲子视角
Xiangyue Jiao1, Junye Jiang2, Ling Yu2
1School of Nursing (X.J., L.C.), Fudan University, Shanghai, China.
Journal of pain and symptom management
|December 14, 2025
概括
患有血液癌症的儿童的息护理需求在整个治疗过程中发生变化. 了解这些不断变化的身体,情感和精神需求是有效支持家庭的关键.
科学领域:
- 儿科瘤学 儿科瘤学
- 抚慰性护理是一种缓解性护理.
- 定性研究是指质量研究.
背景情况:
- 患有血液癌症的儿童在密集治疗期间面临重大挑战.
- 建议早期的息护理,但其在资源有限的环境中的演变是不充分研究的.
研究的目的:
- 描述小儿血液癌症患者和家属不断变化的息护理需求.
- 找出适合不同疾病阶段的支持机会.
主要方法:
- 使用半结构面试对中国32个家庭 (53名参与者) 进行描述性定性研究.
- 在六个疾病阶段探索身体,心理,社会和精神问题.
- 转录的采访的诱导性内容分析.
主要成果:
- 多维需求在疾病轨迹上转移,症状负担在诊断,密集治疗和复发/生命结束时达到顶峰.
- 情绪上的痛苦从震惊演变为悲伤;社会压力包括学业中断和照顾者的负担.
- 诸如希望和尊严之类的精神问题一直存在,随着病情的晚期而加剧.
结论:
- 儿科血液瘤学中的息护理需求是阶段特定的.
- 整合轨迹知情,文化响应的初级息护理可以更好地满足不断变化的需求,增强家庭的弹性.
相关概念视频
Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Pediatric Patients: Drug Distribution
240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Bone Marrow Sampling and Transplants
816
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
816


